Zepbound is a name that comes up often in weight-loss forums and searches, particularly among people in the UK trying to work out whether it is the same as Mounjaro, and people in the USA wanting to know more about dosing, side effects and cost. This guide brings together the key facts about Zepbound, including how it compares to Mounjaro and what is available where you live.

What Is Zepbound?

Zepbound is a brand name for tirzepatide, a dual GIP/GLP-1 receptor agonist made by Eli Lilly. It works by helping regulate appetite and food intake, and is given as a once-weekly injection. Zepbound is approved by the US Food and Drug Administration (FDA) specifically for chronic weight management in adults with obesity, or overweight with a weight-related health condition.

Zepbound Injection or Zepbound Tablets?

Zepbound is only available as a subcutaneous injection, given once a week using a pre-filled single-dose pen. There is currently no tablet or oral form of Zepbound. Some people search for “Zepbound tablets” expecting a pill option, but as with most GLP-1 and GIP-based weight-loss treatments currently on the market, it is injection-only.

Zepbound 5 mg and Other Doses

Zepbound is started at a low dose and increased gradually. The typical dose schedule is 2.5 mg once weekly for the first four weeks, then increasing in 2.5 mg steps roughly every four weeks, through 5 mg, 7.5 mg, 10 mg, 12.5 mg, up to a maximum of 15 mg once weekly. The 5 mg dose is often an early maintenance step for people who do not need to go higher to see meaningful results, though your prescriber will guide dose increases based on how you respond and tolerate each step.

Zepbound or Mounjaro: What’s the Difference?

Zepbound and Mounjaro both contain the same active ingredient, tirzepatide, made by the same manufacturer. The difference is regulatory and geographic rather than clinical: Zepbound is the brand name used in the USA specifically for weight management, while Mounjaro is the brand name used both for type 2 diabetes and, in the UK and much of Europe, for weight management as well. If you are in the UK, Mounjaro is the tirzepatide brand you will be prescribed rather than Zepbound.

Is Zepbound Approved for Diabetes?

No. In the USA, tirzepatide for type 2 diabetes is sold under the brand name Mounjaro, while Zepbound is licensed specifically for weight management. This is different from the UK and EU, where Mounjaro covers both uses. If you are searching for “Zepbound for diabetes,” it is worth knowing that the diabetes-indicated version of tirzepatide in the US market carries the Mounjaro name instead.

Zepbound Side Effects

The most commonly reported side effects of Zepbound are gastrointestinal, including nausea, diarrhoea, vomiting, constipation and reduced appetite. These tend to be most noticeable around dose increases and generally ease as the body adjusts. As with other GLP-1 and GIP-based medications, rarer but more serious side effects can occur, which is why ongoing clinical supervision throughout treatment is important regardless of which tirzepatide brand you are prescribed.

Zepbound UK: Is It Available?

Zepbound itself is not marketed or licensed in the UK. UK patients looking for tirzepatide-based weight-loss treatment are prescribed Mounjaro instead, which contains the same active ingredient and follows a similar dosing schedule. If you have seen “Zepbound” mentioned in US-based content and are based in the UK, Mounjaro is the equivalent treatment available to you through a UK-registered prescriber.

Zepbound USA: Availability and Access

In the United States, Zepbound is available by prescription following an assessment by a licensed healthcare provider, either in person or through a telehealth consultation. Coverage varies significantly between insurance plans, and many patients pay out of pocket or use manufacturer savings programmes where eligible. As with any prescription weight-loss medication, it should only be obtained through a legitimate, licensed pathway involving a genuine clinical assessment.

Getting Tirzepatide Treatment Through Metabolic Slim Clinic

Metabolic Slim Clinic’s specialist doctors can assess your eligibility for Mounjaro, the tirzepatide brand available to patients in the UK and across Europe, and provide a genuine prescription along with ongoing clinical support throughout your treatment. If you have been researching Zepbound and want to know what is available to you locally, book a consultation with one of our doctors today.